Skip to main content

Advertisement

Log in

Family History, and Impact on Clinical Presentation and Prognosis, in a Population-based Breast Cancer Cohort from the Stockholm County

  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

Background

The aim of the present study was to define the proportion of different levels of family history in a cohort of consecutive breast cancer patients from the Stockholm region, and to assess whether familial breast cancer has phenotypic traits different from those of sporadic patients.

Methods

All incident breast cancer patients in a 19-month period were eligible for the study and 70% (489/696) participated. The family history and clinical parameters were obtained from questionnaires and medical records.

Results

In total 35% had a family history. Age at onset was 58.9 years in the familial group vs. 60.7 years in the sporadic patients (= 0.14) and 8% of the familial patients had bilateral breast cancer compared to 4% in the sporadic group (= 0.08). There were 31% node positive tumors in the sporadic group vs. 22% in the cases with family history (= 0.04). Hormonal background, treatment and prognosis (median follow-up 4.7 years) were not related to family history.

Conclusion

In addition to high-risk familial breast and breast-ovarian cancer, constituting about 10% of all breast cancer cases, another 25% of the breast cancer cases have a family history, a group hypothetically valuable for association studies on low-risk genes. In contrast to previous reports, we did not observe a relationship between family history and phenotypic traits. A possible explanation for this can be different study design. The considerable heterogeneity in familial breast cancer means that different criteria for familiality can influence the result. Furthermore, our study was prospective and population based and included paternal inheritance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

ER:

estrogen receptor

HR:

hazard rate ratio

RR:

relative risk

CI:

confidence interval

FH+:

patients with family history

NS:

no statistically significant difference

PgR:

progesterone receptor

BRCA:

breast cancer gene

HRT:

hormone replacement therapy

FH:

family history

FH−:

sporadic patients

References

  1. Socialstyrelsen (2002) Epidemiologiskt centrum., Medicinalstyrelsen. and Socialstyrelsen. Cancerregistret. Cancer incidence in Sweden. Socialstyrelsen, Statistik. Hälsa och sjukdomar, Stockholm

  2. Newman B, Austin MA, Lee M, King MC (1988) Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proc Natl Acad Sci USA 85:3044–3048

    Article  PubMed  CAS  Google Scholar 

  3. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66–71

    Article  PubMed  CAS  Google Scholar 

  4. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D et al. (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12–13. Science 265:2088–2090

    Article  PubMed  CAS  Google Scholar 

  5. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M et al. (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62:676–689

    Article  PubMed  CAS  Google Scholar 

  6. Malkin D (1994) p53 and the Li-Fraumeni syndrome. Biochim Biophys Acta 1198:197–213

    PubMed  Google Scholar 

  7. Eng C (1998) Genetics of Cowden syndrome: through the looking glass of oncology. Int J Oncol 12:701–710

    PubMed  CAS  Google Scholar 

  8. Boardman LA, Thibodeau SN, Schaid DJ, Lindor NM, McDonnell SK, Burgart LJ, Ahlquist DA, Podratz KC, Pittelkow M, Hartmann LC (1998) Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med 128:896–899

    PubMed  CAS  Google Scholar 

  9. Swift M, Reitnauer PJ, Morrell D, Chase CL (1987) Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 316:1289–1294

    Article  PubMed  CAS  Google Scholar 

  10. Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA (1997) Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 71:800–809

    Article  PubMed  CAS  Google Scholar 

  11. Weber BL, Nathanson KL (2000) Low penetrance genes associated with increased risk for breast cancer. Eur J Cancer 36:1193–1199

    Article  PubMed  CAS  Google Scholar 

  12. Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA, Easton DF (1999) A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 8:843–854

    PubMed  CAS  Google Scholar 

  13. Antoniou AC, Pharoah PD, McMullan G, Day NE, Ponder BA, Easton D (2001) Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol 21:1–18

    Article  PubMed  CAS  Google Scholar 

  14. Adami HO, Hansen J, Jung B, Rimsten A (1980) Familiality in breast cancer: a case-control study in a Sweden population. Br J Cancer 42:71–77

    PubMed  CAS  Google Scholar 

  15. Lynch HT, Lynch JF (1986) Breast cancer genetics in an oncology clinic: 328 consecutive patients. Cancer Genet Cytogenet 22:369–371

    Article  PubMed  CAS  Google Scholar 

  16. Lindblom A, Rotstein S, Larsson C, Nordenskjold M, Iselius L (1993) Hereditary breast cancer in Sweden: a predominance of maternally inherited cases. Breast Cancer Res Treat 24:159–165

    Article  Google Scholar 

  17. Israeli D, Tartter PI, Brower ST, Mizrachy B, Bratton J (1994) The significance of family history for patients with carcinoma of the breast. J Am Coll Surg 179:29–32

    PubMed  CAS  Google Scholar 

  18. Eerola H, Blomqvist C, Pukkala E, Pyrhonen S, Nevanlinna H (2000) Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients? Eur J Cancer 36:1143–1148

    Article  PubMed  CAS  Google Scholar 

  19. Doepel M, Kellokumpu IH, v Smitten KA (1995) Hereditary breast cancer in Finnish women. Eur J Surg 161:805–809

    PubMed  CAS  Google Scholar 

  20. Pharoah PD, Lipscombe JM, Redman KL, Day NE, Easton DF, Ponder BA (2000) Familial predisposition to breast cancer in a British population: implications for prevention. Eur J Cancer 36:773–779

    Article  PubMed  CAS  Google Scholar 

  21. Tsuchiya A, Kanno M, Nomizu T, Hatakeyama Y, Kimijima I, Abe R (1998) Clinical characteristics of breast cancer patients with family history. Fukushima J Med Sci 44:35–41

    PubMed  CAS  Google Scholar 

  22. Wobbes T, van de Wiel MP, van der Sluis RF, Theeuwes AG (1987) The effect of familiality on clinical presentation and survival in mammary carcinoma. Eur J Surg Oncol l13:119–121

    Google Scholar 

  23. Russo A, Herd-Smith A, Gestri D, Bianchi S, Vezzosi V, Rosselli Del Turco M, Cardona G (2002) Does family history influence survival in breast cancer cases? Int J Cancer 99:427–430

    Article  PubMed  CAS  Google Scholar 

  24. Molino A, Giovannini M, Pedersini R, Frisinghelli M, Micciolo R, Mandara M, Pavarana M, Cetto GL (2004) Correlations between family history and cancer characteristics in 2256 breast cancer patients. Br J Cancer 91:96–98

    Article  PubMed  CAS  Google Scholar 

  25. Anderson DE (1971) Some characteristics of familial breast cancer. Cancer 28:1500–1504

    Article  PubMed  CAS  Google Scholar 

  26. Adami HO, Hansen J, Jung B, Rimsten A (1981) Characteristics of familial breast cancer in Sweden: absence of relation to age and unilateral versus bilateral disease. Cancer 48:1688–1695

    Article  PubMed  CAS  Google Scholar 

  27. Loman N, Johannsson O, Bendahl PO, Borg A, Ferno M, Olsson H (1998) Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes. Cancer 83:310–319

    Article  PubMed  CAS  Google Scholar 

  28. Pathology of familial breast cancer (1997) differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium. Lancet 349:1505–1510

    Google Scholar 

  29. Chappuis PO, Rosenblatt J, Foulkes WD (1999) The influence of familial and hereditary factors on the prognosis of breast cancer. Ann Oncol 10:1163–1170

    Article  PubMed  CAS  Google Scholar 

  30. Thalib L, Wedren S, Granath F, Adami HO, Rydh B, Magnusson C, Hall P (2004) Breast cancer prognosis in relation to family history of breast and ovarian cancer. Br J Cancer 90:1378–1381

    Article  PubMed  CAS  Google Scholar 

  31. Kinoshita T, Fukutomi T, Iwamoto E, Akashi-Tanaka S (2004) Prognosis of breast cancer patients with familial history classified according to their menopausal status. Br J Cancer 10:218–222

    Google Scholar 

  32. Magnusson C, Colditz G, Rosner B, Bergstrom R, Persson I (1998) Association of family history and other risk factors with breast cancer risk (Sweden). Cancer Causes Control 9:259–267

    Article  PubMed  CAS  Google Scholar 

  33. Olsson H, Bladstrom A (2002) A cohort study of reproductive factors and family history of breast cancer in southern Sweden. Breast Cancer Res Treat 76:203–209

    Article  PubMed  CAS  Google Scholar 

  34. Jernstrom HC, Johannsson OT, Loman N, Borg A, Olsson H (1999) Reproductive factors in hereditary breast cancer. Breast Cancer Res Treat 58:295–301

    Article  PubMed  CAS  Google Scholar 

  35. Colditz GA, Rosner BA, Speizer FE (1996) Risk factors for breast cancer according to family history of breast cancer. For the Nurses’ Health Study Research Group. J Natl Cancer Inst 88:365–371

    PubMed  CAS  Google Scholar 

  36. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403–410

    PubMed  CAS  Google Scholar 

  37. Szabo CI, King MC (1997) Population genetics of BRCA1 and BRCA2. Am J Hum Genet 60:1013–1020

    PubMed  CAS  Google Scholar 

  38. Arver B, Borg A, Lindblom A (2001) First BRCA1 and BRCA2 gene testing implemented in the health care system of Stockholm. Genet Test 5:1–8

    Article  PubMed  CAS  Google Scholar 

  39. Arver B, Claro A, Langerod A, Borresen-Dale AL, Lindblom A (1999) BRCA1 screening in patients with a family history of breast or ovarian cancer. Genet Test 3:223–226

    PubMed  CAS  Google Scholar 

  40. Zelada-Hedman M, Wasteson Arver B, Claro A, Chen J, Werelius B, Kok H, Sandelin K, Hakansson S, Andersen TI, Borg A, Borresen Dale AL, Lindblom A (1997) A screening for BRCA1 mutations in breast and breast–ovarian cancer families from the Stockholm region. Cancer Res 57:2474–2477

    PubMed  CAS  Google Scholar 

  41. Chen J, Hedman MZ, Arver BW, Sigurdsson S, Eyfjord JE, Lindblom A (1998) BRCA2 germline mutations in Swedish breast cancer families. Eur J Hum Genet 6:134–139

    Article  PubMed  CAS  Google Scholar 

  42. Mattsson B, Rutqvist LE, Wallgren A (1985) Undernotification of diagnosed cancer cases to the Stockholm Cancer Registry. Int J Epidemiol 14:64–69

    PubMed  CAS  Google Scholar 

  43. Margolin S, Werelius B, Fornander T, Lindblom A (2004) BRCA1 mutations in a population-based study of breast cancer in Stockholm County. Genet Test 8:127–132

    PubMed  CAS  Google Scholar 

  44. Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evans C, Deacon J, Stratton MR (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91:943–949

    Article  PubMed  CAS  Google Scholar 

  45. Hutson SP (2003) Attitudes and psychological impact of genetic testing, genetic counseling, and breast cancer risk assessment among women at increased risk. Oncol Nurs Forum 30:241–246

    PubMed  Google Scholar 

  46. Claus EB, Schildkraut JM, Thompson WD, Risch NJ (1996) The genetic attributable risk of breast and ovarian cancer. Cancer 77:2318–2324

    Article  PubMed  CAS  Google Scholar 

  47. Claus EB, Risch N, Thompson WD (1994) Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 73:643–651

    Article  PubMed  CAS  Google Scholar 

  48. Theis B, Boyd N, Lockwood G, Tritchler D (1994) Accuracy of family cancer history in breast cancer patients. Eur J Cancer Prev 3:321–327

    Article  PubMed  CAS  Google Scholar 

  49. Mohammed SN, Smith P, Hodgson SV, Fentiman IS, Miles DW, Barnes DM, Millis RR, Rubens RD (1998) Family history and survival in premenopausal breast cancer. Br J Cancer 77:2252–2256

    PubMed  CAS  Google Scholar 

  50. Vårdprogram Ba, Onkologiskt Centrum Stockholm-Gotland

  51. Hedenfalk I, Ringner M, Ben-Dor A, Yakhini Z, Chen Y, Chebil G, Ach R, Loman N, Olsson H, Meltzer P, Borg A, Trent J (2003) Molecular classification of familial non-BRCA1/BRCA2 breast cancer. Proc Natl Acad Sci USA 100:2532–2537

    Article  PubMed  CAS  Google Scholar 

  52. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K (2000) Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78–85

    Article  PubMed  CAS  Google Scholar 

  53. Peto J, Mack TM (2000) High constant incidence in twins and other relatives of women with breast cancer. Nat Genet 26:411–414

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sara Margolin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Margolin, S., Johansson, H., Rutqvist, L.E. et al. Family History, and Impact on Clinical Presentation and Prognosis, in a Population-based Breast Cancer Cohort from the Stockholm County. Familial Cancer 5, 309–321 (2006). https://doi.org/10.1007/s10689-006-7851-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10689-006-7851-3

Keywords

Navigation